血清肌酐与肾损伤生物标志物诊断组织学急性肾小管损伤的表现
本研究为多中心前瞻性队列的横断面分析,纳入581例住院死亡肾脏捐献者,在器官获取时行肾活检评估组织学急性肾小管损伤。结果显示,基于血肌酐的AKI诊断对组织学急性肾小管损伤的鉴别能力较差,49%的重度损伤者无AKI;尿NGAL的AUROC略高于血肌酐,但整体仍不高,其他尿标志物无显著优势。
要点
- 血肌酐诊断组织学急性肾小管损伤的AUROC仅0.52-0.58,49%重度损伤者无AKI。
- 尿NGAL诊断重度损伤的AUROC为0.67,略优于血肌酐(P=0.03)。
- 尿L-FABP、IL-18、KIM-1诊断组织学损伤的AUROC未显著高于血肌酐。
核心结论
- 在住院死亡肾脏捐献者中,血肌酐及尿L-FABP、IL-18、KIM-1对组织学急性肾小管损伤的诊断准确性不足。
- 尿NGAL的鉴别能力略高于血肌酐,但整体AUROC仍仅为中等水平。
研究设计与样本
- 多中心前瞻性队列的横断面分析,纳入581例住院死亡肾脏捐献者,在器官获取时行肾活检进行组织学评估。
主要发现
- 581例捐献者中,98例(17%)有轻度急性肾小管损伤,57例(10%)有重度急性肾小管损伤。
- 基于血肌酐的AKI对组织学急性肾小管损伤诊断性能差,49%的重度损伤者未达到AKI标准。
- 血肌酐变化诊断重度损伤的AUROC为0.58(95%CI 0.49-0.67),诊断任何程度损伤的AUROC为0.52(95%CI 0.45-0.58)。
- 尿NGAL诊断重度损伤的AUROC为0.67(95%CI 0.60-0.74;P=0.03),诊断任何程度损伤的AUROC为0.60(95%CI 0.55-0.66;P=0.005),均高于血肌酐。
- 在无血肌酐AKI的捐献者中,尿NGAL浓度随急性肾小管损伤严重程度增加而升高(亚临床AKI)。
关键数值与推荐
- 血肌酐变化诊断重度急性肾小管损伤的AUROC为0.58(95%CI 0.49-0.67)。
- 血肌酐变化诊断任何急性肾小管损伤的AUROC为0.52(95%CI 0.45-0.58)。
- 尿NGAL诊断重度急性肾小管损伤的AUROC为0.67(95%CI 0.60-0.74;P=0.03)。
- 尿NGAL诊断任何急性肾小管损伤的AUROC为0.60(95%CI 0.55-0.66;P=0.005)。
临床怎么用
- 基于血肌酐的AKI定义可能漏诊近半数组织学重度急性肾小管损伤,临床应警惕亚临床AKI。
- 尿NGAL可作为辅助标志物帮助识别无血肌酐升高的亚临床急性肾小管损伤。
- 尿L-FABP、IL-18、KIM-1在此场景下不优于血肌酐,不建议单独用于诊断组织学损伤。
局限性
- 死亡肾脏捐献者的AKI病因谱可能与一般住院人群不同,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The diagnosis of acute kidney injury (AKI), which is currently defined as an increase in serum creatinine (Scr) concentration, provides little information on the condition's actual cause. To improve phenotyping of AKI, many urinary biomarkers of tubular injury are being investigated. Because AKI cases are not frequently biopsied, the diagnostic accuracy of concentrations of Scr and urinary biomarkers for histologic acute tubular injury is unknown. STUDY DESIGN: Cross-sectional analysis from multicenter prospective cohort. SETTINGS & PARTICIPANTS: Hospitalized deceased kidney donors on whom kidney biopsies were performed at the time of organ procurement for histologic evaluation. PREDICTORS: (1) AKI diagnosed by change in Scr concentration during donor hospitalization and (2) concentrations of urinary biomarkers (neutrophil gelatinase-associated lipocalin [NGAL], liver-type fatty acid-binding protein [L-FABP], interleukin 18 [IL-18], and kidney injury molecule 1 [KIM-1]) measured at organ procurement. OUTCOME: Histologic acute tubular injury. RESULTS: Of 581 donors, 98 (17%) had mild acute tubular injury and 57 (10%) had severe acute tubular injury. Overall, Scr-based AKI had poor diagnostic performance for identifying histologic acute tubular injury and 49% of donors with severe acute tubular injury did not have AKI. The area under the receiver operating characteristic curve (AUROC) of change in Scr concentration for diagnosing severe acute tubular injury was 0.58 (95% CI, 0.49-0.67) and for any acute tubular injury was 0.52 (95% CI, 0.45-0.58). Compared with Scr concentration, NGAL concentration demonstrated higher AUROC for diagnosing both severe acute tubular injury (0.67; 95% CI, 0.60-0.74; P=0.03) and any acute tubular injury (0.60; 95% CI, 0.55-0.66; P=0.005). In donors who did not have Scr-based AKI, NGAL concentrations were higher with increasing severities of acute tubular injury (subclinical AKI). However, compared with Scr concentration, AUROCs for acute tubular injury diagnosis were not significantly higher for urinary L-FABP, IL-18, or KIM-1. LIMITATIONS: The spectrum of AKI cause in deceased donors may be different from that of a general hospitalized population. CONCLUSIONS: Concentrations of Scr and kidney injury biomarkers (L-FABP, IL-18, and KIM-1) lack accuracy for diagnosing acute tubular injury in hospitalized deceased donors. Although urinary NGAL concentration had slightly higher discrimination for acute tubular injury than did Scr concentration, its overall AUROC was still modest.
引用
- Moledina DG, Hall IE, Thiessen-Philbrook H, et al. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury. Am J Kidney Dis. 2017. PMID: 28844586. doi:10.1053/j.ajkd.2017.06.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。